Perfinity and Thermo Fisher Scientific Sign Co-Marketing Agreement
Friday, June 14, 2013
The agreement will see the companies co-market an automated protein sample preparation and analysis system.
DNA Sequencing Reveals Mucosal Melanoma's Bullseye
Wednesday, June 12, 2013
Scientists have found a molecular 'bullseye' for a rare form of melanoma, opening up opportunities for new targeted treatment.
Trinean signs a global agreement with Bayer CropScience
Wednesday, June 12, 2013
Bayer will use Trinean’s technology for biomolecule QC using spectral content profiling.
TB Bacteria's Trash-Eating Inspires Search for New Drugs
Tuesday, June 11, 2013
When hijacking a garbage truck, one might as well make use of the trash. That logic drives how tuberculosis-causing bacteria feed, say Cornell scientists.
BioTek Announces Establishment of Japanese Office
Monday, June 10, 2013
BioTek Japan will be fully functional by July 1, 2013.
QIAGEN Expands Pipeline of Promising New Biomarkers for Development of Companion Diagnostics
Monday, June 10, 2013
Several lymphoma-related biomarkers, including EZH2 Y641 gene mutations, rights acquired from British Columbia Cancer Agency.
Pronota is to Receive Patent on Biomarker for Diagnosing Renal Failure
Friday, June 07, 2013
USPTO has allowed Company’s patent for the use of a blood-based biomarker LG3.
Biolog’s PM Technology Unlocks Critical Clue in Understanding Autism
Friday, June 07, 2013
Discovery demonstrates advantage of metabolic over genetic screening.
4SC Gives Update on the Clinical Development of its Lead Cancer Compound Resminostat
Thursday, May 30, 2013
Data from completed Phase I part of SHORE study confirms the safety of the resminostat FOLFIRI combination and showing encouraging signs of clinical benefit
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 1 - 10 of 3100 |
|
|
